IP Verse

Long - Acting Formulations Of Insulins - EP2571517B9

PatentPatent Analysis

EP2571517

SANOFI
Application Number
EP11720115A
Filing Date
May 18, 2011
Status
Patent Maintained As Amended
May 17, 2024
Grant Date
Oct 16, 2024
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP4056212B1
EP3506931B1
EP3889181B1

Bibliography

The patent EP2571517B9 was granted to Sanofi on Oct 16, 2024 following the initial filing on May 18, 2011 under the application number EP11720115A . The current legal status of the patent is Patent Maintained As Amended.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

COOKEDec 24, 2018ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents